Andrei Horia Iagaru MD

Nuclear Medicine•Stanford, CA

Professor, Radiology, Stanford University Medical Center

Join to View Full Profile

300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-498-5047

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2004 - 2006
Graduate HospitalInternship, Internal Medicine, 2003 - 2004
Carol Davila University of Medicine and PharmacyClass of 2000

Certifications & Licensure

CA State Medical License 2005 - 2027
PA State Medical License 2003 - 2004
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA Start of enrollment: 2007 May 01
Withdrawn
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases Start of enrollment: 2006 Jan 01
Completed
Phase 2
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy Start of enrollment: 2007 Aug 01
Completed
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
No longer available
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Start of enrollment: 2014 Dec 01
Terminated
Not Applicable
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment Start of enrollment: 2017 May 20
Completed
Phase 2, Phase 3
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery Start of enrollment: 2016 Apr 18
Completed
Phase 2, Phase 3
Standard PET/CT vs. Digital PET/CT Start of enrollment: 2017 Mar 29
Completed
Not Applicable
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation Start of enrollment: 2017 Aug 02
Terminated
Phase 2
Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors Start of enrollment: 2017 Feb 15
Completed
Not Applicable
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer Start of enrollment: 2017 Apr 10
Completed
Phase 2
PET/MRI Evaluation of Cardiac Amyloid Start of enrollment: 2016 May 26
Completed
Early Phase 1
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals Start of enrollment: 2014 May 27
Completed
Phase 2
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
No longer available
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer Start of enrollment: 2020 Dec 15
Completed
Phase 2
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer Start of enrollment: 2019 Jan 14
Completed
Phase 2
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy Start of enrollment: 2019 Apr 09
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Correction to: Guiding principles on the education and practice of theranostics.
Thomas N B Pascual, Diana Paez, Andrei Iagaru, Gopi Gnanasegaran, Sze Ting Lee
European Journal of Nuclear Medicine and Molecular Imaging. 2025-11-01
5 citations
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review.
Nasibeh Mohseninia, Roya Eisazadeh, Seyed Ali Mirshahvalad, Nazanin Zamani-Siahkali, Anton Amadeus Hörmann
Seminars in Nuclear Medicine. 2025-09-01
GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy.
Aurélien Callaud, Heying Duan, Elif Hindié, Clément Morgat, Andrei Iagaru
Seminars in Nuclear Medicine. 2025-08-11

Journal Articles

Visualization of Diagnostic and Therapeutic Targets in Glioma with Molecular Imaging
Chirag B Patel, Guofan Xu, Andrei Iagaru, Frontiers in Immunology
18F-FPPRGD2 PET/CT in Patients with Metastatic Renal Cell Cancer
Alice C Fan, Andrei Iagaru, European Journal of Nuclear Medicine and Molecular Imaging

Press Mentions

GE HealthCare Renews Research Partnership with Stanford MedicineJune 20th, 2025
Stanford Medicine Department of Radiology to Continue Advancements in Molecular Imaging with New Long Axial Field of View PET/CT Technology with GE HealthCareJune 19th, 2025
GE HealthCare and Stanford Medicine Renew Research Collaboration to Advance Total Body PET/CT TechnologyJune 19th, 2025
Join now to see all